Skip to main content
. 2020 May 20;17(5):e1003112. doi: 10.1371/journal.pmed.1003112

Fig 5. Metabolites associated with type 2 diabetes (T2D) progression in longitudinal study.

Fig 5

(A) 10 Metabolites significantly differ in progressors versus non-progressors across T2D development. p-Values < 0.05; p-values were obtained by Type III ANOVA test in a mixed effect model. False discovery rate (FDR) values < 0.2; FDR values were obtained by correcting p-value by Benjamini–Hochberg method. (B) Delta values (upper panels) and trajectory (lower panels) of 10 metabolites within all individuals during diabetes progression.